Which has higher valuation & earnings, NUTX or UXIN?

Nutex Health has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nutex Health $875.26M 1.41 $70.79M $12.94 13.88 Uxin $463.27M 0.83 -$39.69M -$0.21 N/A

Is NUTX or UXIN more profitable?

Nutex Health has a net margin of 10.95% compared to Uxin's net margin of -8.46%. Nutex Health's return on equity of 23.50% beat Uxin's return on equity. Company Net Margins Return on Equity Return on Assets Nutex Health 10.95% 23.50% 10.47% Uxin -8.46% N/A -11.60%

Which has better earnings and valuation, ACVA or UXIN?

Uxin has lower revenue, but higher earnings than ACV Auctions. ACV Auctions is trading at a lower price-to-earnings ratio than Uxin, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ACV Auctions $759.61M 1.62 -$66.14M -$0.35 N/A Uxin $463.27M 0.83 -$39.69M -$0.21 N/A

Is ACVA or UXIN more profitable?

ACV Auctions has a net margin of -7.97% compared to Uxin's net margin of -8.46%. Uxin's return on equity of 0.00% beat ACV Auctions' return on equity. Company Net Margins Return on Equity Return on Assets ACV Auctions -7.97% -5.52% -2.08% Uxin -8.46% N/A -11.60%

Which has better valuation & earnings, UXIN or RDWR?

Radware has lower revenue, but higher earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Radware, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Uxin $463.27M 0.83 -$39.69M -$0.21 N/A Radware $301.85M 4.24 $20.26M $0.43 70.72

Is UXIN or RDWR more profitable?

Radware has a net margin of 6.28% compared to Uxin's net margin of -8.46%. Radware's return on equity of 7.69% beat Uxin's return on equity. Company Net Margins Return on Equity Return on Assets Uxin -8.46% N/A -11.60% Radware 6.28% 7.69% 4.44%

Do analysts prefer UXIN or BRAI?

Uxin currently has a consensus price target of $4.50, suggesting a potential upside of 152.81%. Braiin has a consensus price target of $10.00, suggesting a potential upside of 83.49%. Given Uxin's higher possible upside, analysts plainly believe Uxin is more favorable than Braiin. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Uxin 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Braiin 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, UXIN or BRAI?

Braiin has lower revenue, but higher earnings than Uxin. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Uxin $463.27M 0.83 -$39.69M -$0.21 N/A Braiin $73.41M 15.30 N/A N/A N/A

Is UXIN or BRAI more profitable?

Braiin has a net margin of 0.00% compared to Uxin's net margin of -8.46%. Company Net Margins Return on Equity Return on Assets Uxin -8.46% N/A -11.60% Braiin N/A N/A N/A

Which has higher earnings and valuation, UXIN or LZ?

LegalZoom.com has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than LegalZoom.com, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Uxin $463.27M 0.83 -$39.69M -$0.21 N/A LegalZoom.com $756.04M 1.65 $15.43M $0.06 121.33

Is UXIN or LZ more profitable?

LegalZoom.com has a net margin of 1.46% compared to Uxin's net margin of -8.46%. LegalZoom.com's return on equity of 11.53% beat Uxin's return on equity. Company Net Margins Return on Equity Return on Assets Uxin -8.46% N/A -11.60% LegalZoom.com 1.46% 11.53% 3.93%

Uxin (UXIN) Competitors

$1.78 +0.12 (+7.23%)

Closing price 07/8/2026 04:00 PM Eastern

Extended Trading

$1.75 -0.03 (-1.69%)

As of 07/8/2026 07:57 PM Eastern

Compare

UXIN vs. NUTX, ACVA, RDWR, BRAI, and LZ

Should you buy Uxin stock or one of its competitors? MarketBeat compares Uxin with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Uxin include Nutex Health (NUTX), ACV Auctions (ACVA), Radware (RDWR), Braiin (BRAI), and LegalZoom.com (LZ). These companies are all part of the "business services" industry.

How does Uxin compare to Nutex Health?

Nutex Health (NASDAQ:NUTX) and Uxin (NASDAQ:UXIN) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Nutex Health has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$875.26M	1.41	$70.79M	$12.94	13.88
Uxin	$463.27M	0.83	-$39.69M	-$0.21	N/A

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 22.4% of Uxin shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by company insiders. Comparatively, 62.9% of Uxin shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Nutex Health presently has a consensus price target of $243.33, indicating a potential upside of 35.52%. Uxin has a consensus price target of $4.50, indicating a potential upside of 152.81%. Given Uxin's higher probable upside, analysts plainly believe Uxin is more favorable than Nutex Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Uxin	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Nutex Health had 2 more articles in the media than Uxin. MarketBeat recorded 2 mentions for Nutex Health and 0 mentions for Uxin. Nutex Health's average media sentiment score of 0.75 beat Uxin's score of 0.00 indicating that Nutex Health is being referred to more favorably in the media.

Company	Overall Sentiment
Nutex Health	Positive
Uxin	Neutral

Nutex Health has a net margin of 10.95% compared to Uxin's net margin of -8.46%. Nutex Health's return on equity of 23.50% beat Uxin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutex Health	10.95%	23.50%	10.47%
Uxin	-8.46%	N/A	-11.60%

Nutex Health has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, Uxin has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

Summary

Nutex Health beats Uxin on 12 of the 16 factors compared between the two stocks.

How does Uxin compare to ACV Auctions?

ACV Auctions (NYSE:ACVA) and Uxin (NASDAQ:UXIN) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

In the previous week, ACV Auctions had 3 more articles in the media than Uxin. MarketBeat recorded 3 mentions for ACV Auctions and 0 mentions for Uxin. ACV Auctions' average media sentiment score of 0.08 beat Uxin's score of 0.00 indicating that ACV Auctions is being referred to more favorably in the media.

Company	Overall Sentiment
ACV Auctions	Neutral
Uxin	Neutral

ACV Auctions has a net margin of -7.97% compared to Uxin's net margin of -8.46%. Uxin's return on equity of 0.00% beat ACV Auctions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ACV Auctions	-7.97%	-5.52%	-2.08%
Uxin	-8.46%	N/A	-11.60%

ACV Auctions presently has a consensus price target of $10.14, suggesting a potential upside of 43.90%. Uxin has a consensus price target of $4.50, suggesting a potential upside of 152.81%. Given Uxin's higher probable upside, analysts clearly believe Uxin is more favorable than ACV Auctions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ACV Auctions	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40
Uxin	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Uxin has lower revenue, but higher earnings than ACV Auctions. ACV Auctions is trading at a lower price-to-earnings ratio than Uxin, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ACV Auctions	$759.61M	1.62	-$66.14M	-$0.35	N/A
Uxin	$463.27M	0.83	-$39.69M	-$0.21	N/A

88.6% of ACV Auctions shares are held by institutional investors. Comparatively, 22.4% of Uxin shares are held by institutional investors. 4.4% of ACV Auctions shares are held by company insiders. Comparatively, 62.9% of Uxin shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ACV Auctions has a beta of 1.82, indicating that its stock price is 82% more volatile than the broader market. Comparatively, Uxin has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Summary

ACV Auctions beats Uxin on 11 of the 17 factors compared between the two stocks.

How does Uxin compare to Radware?

Uxin (NASDAQ:UXIN) and Radware (NASDAQ:RDWR) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

22.4% of Uxin shares are owned by institutional investors. Comparatively, 73.1% of Radware shares are owned by institutional investors. 62.9% of Uxin shares are owned by insiders. Comparatively, 21.6% of Radware shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Radware has a net margin of 6.28% compared to Uxin's net margin of -8.46%. Radware's return on equity of 7.69% beat Uxin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Uxin	-8.46%	N/A	-11.60%
Radware	6.28%	7.69%	4.44%

Uxin currently has a consensus target price of $4.50, suggesting a potential upside of 152.81%. Radware has a consensus target price of $30.00, suggesting a potential downside of 1.35%. Given Uxin's higher possible upside, analysts plainly believe Uxin is more favorable than Radware.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Uxin	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Radware	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Radware has lower revenue, but higher earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Radware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Uxin	$463.27M	0.83	-$39.69M	-$0.21	N/A
Radware	$301.85M	4.24	$20.26M	$0.43	70.72

Uxin has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Radware has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

In the previous week, Radware had 4 more articles in the media than Uxin. MarketBeat recorded 4 mentions for Radware and 0 mentions for Uxin. Radware's average media sentiment score of 0.65 beat Uxin's score of 0.00 indicating that Radware is being referred to more favorably in the news media.

Company	Overall Sentiment
Uxin	Neutral
Radware	Positive

Summary

Radware beats Uxin on 10 of the 14 factors compared between the two stocks.

How does Uxin compare to Braiin?

Uxin (NASDAQ:UXIN) and Braiin (NASDAQ:BRAI) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

Uxin currently has a consensus price target of $4.50, suggesting a potential upside of 152.81%. Braiin has a consensus price target of $10.00, suggesting a potential upside of 83.49%. Given Uxin's higher possible upside, analysts plainly believe Uxin is more favorable than Braiin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Uxin	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Braiin	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Braiin had 21 more articles in the media than Uxin. MarketBeat recorded 21 mentions for Braiin and 0 mentions for Uxin. Braiin's average media sentiment score of 0.15 beat Uxin's score of 0.00 indicating that Braiin is being referred to more favorably in the news media.

Company	Overall Sentiment
Uxin	Neutral
Braiin	Neutral

22.4% of Uxin shares are owned by institutional investors. 62.9% of Uxin shares are owned by company insiders. Comparatively, 47.9% of Braiin shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Braiin has a net margin of 0.00% compared to Uxin's net margin of -8.46%.

Company	Net Margins	Return on Equity	Return on Assets
Uxin	-8.46%	N/A	-11.60%
Braiin	N/A	N/A	N/A

Braiin has lower revenue, but higher earnings than Uxin.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Uxin	$463.27M	0.83	-$39.69M	-$0.21	N/A
Braiin	$73.41M	15.30	N/A	N/A	N/A

Summary

Braiin beats Uxin on 5 of the 9 factors compared between the two stocks.

How does Uxin compare to LegalZoom.com?

Uxin (NASDAQ:UXIN) and LegalZoom.com (NASDAQ:LZ) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

LegalZoom.com has a net margin of 1.46% compared to Uxin's net margin of -8.46%. LegalZoom.com's return on equity of 11.53% beat Uxin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Uxin	-8.46%	N/A	-11.60%
LegalZoom.com	1.46%	11.53%	3.93%

Uxin presently has a consensus target price of $4.50, suggesting a potential upside of 152.81%. LegalZoom.com has a consensus target price of $8.25, suggesting a potential upside of 13.32%. Given Uxin's higher probable upside, analysts plainly believe Uxin is more favorable than LegalZoom.com.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Uxin	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
LegalZoom.com	3 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

LegalZoom.com has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than LegalZoom.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Uxin	$463.27M	0.83	-$39.69M	-$0.21	N/A
LegalZoom.com	$756.04M	1.65	$15.43M	$0.06	121.33

Uxin has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, LegalZoom.com has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

In the previous week, LegalZoom.com had 8 more articles in the media than Uxin. MarketBeat recorded 8 mentions for LegalZoom.com and 0 mentions for Uxin. LegalZoom.com's average media sentiment score of 0.60 beat Uxin's score of 0.00 indicating that LegalZoom.com is being referred to more favorably in the news media.

Company	Overall Sentiment
Uxin	Neutral
LegalZoom.com	Positive

22.4% of Uxin shares are held by institutional investors. Comparatively, 82.0% of LegalZoom.com shares are held by institutional investors. 62.9% of Uxin shares are held by insiders. Comparatively, 5.9% of LegalZoom.com shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

LegalZoom.com beats Uxin on 13 of the 15 factors compared between the two stocks.

Get Uxin News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UXIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UXIN vs. The Competition

Export

Metric	Uxin	INTERNET SERVICES Industry	Computer Sector	NASDAQ Exchange
Market Cap	$359.30M	$168.67B	$38.47B	$12.46B
Dividend Yield	N/A	4.31%	3.19%	7.39%
P/E Ratio	-8.48	19.47	168.83	24.24
Price / Sales	0.83	54.18	599.15	96.53
Price / Cash	N/A	25.29	45.01	56.96
Price / Book	-11.87	2.33	9.47	6.38
Net Income	-$39.69M	$5.67B	$1.07B	$331.19M
7 Day Performance	9.20%	1.35%	-1.20%	-1.32%
1 Month Performance	-17.97%	0.53%	-0.88%	1.27%
1 Year Performance	-51.63%	-10.57%	139.03%	20.73%

Uxin Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UXIN Uxin	2.2054 of 5 stars	$1.78 +7.2%	$4.50 +152.8%	-51.5%	$359.30M	$463.27M	N/A	2,437
NUTX Nutex Health	3.5932 of 5 stars	$193.54 -1.5%	$243.33 +25.7%	+30.3%	$1.35B	$875.26M	15.19	1,150	News Coverage
ACVA ACV Auctions	3.0857 of 5 stars	$7.43 +1.7%	$10.14 +36.5%	-56.5%	$1.27B	$759.61M	N/A	3,200	News Coverage
RDWR Radware	1.4703 of 5 stars	$30.32 +2.1%	$30.00 -1.1%	-1.3%	$1.25B	$301.85M	70.51	1,296
BRAI Braiin	4.458 of 5 stars	$5.73 -5.0%	$10.00 +74.5%	N/A	$1.24B	$73.41M	N/A	5	Trending News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UXIN) was last updated on 7/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Uxin (UXIN) Competitors